Trial Outcomes & Findings for Evaluating the Influence of Apnea on Cardiac Function Using Cardiac Magnetic Resonance Imaging. (NCT NCT02280226)

NCT ID: NCT02280226

Last Updated: 2018-02-07

Results Overview

Alteration of cardiac function in subjects undergoing maximum apnea.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

17 participants

Primary outcome timeframe

every minute under apnea (from 0 up to 9 minutes and rest) depending on personal best with a mean of 5 measurements

Results posted on

2018-02-07

Participant Flow

Participant milestones

Participant milestones
Measure
Deliberate Apnea Group
Overall Study
STARTED
17
Overall Study
COMPLETED
17
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Deliberate Apnea Group
n=17 Participants
Subjects undergo maximum apnea. magnetic resonance imaging (MRI)
Age, Continuous
40 years
STANDARD_DEVIATION 11 • n=17 Participants
Sex: Female, Male
Female
2 Participants
n=17 Participants
Sex: Female, Male
Male
15 Participants
n=17 Participants
Region of Enrollment
Germany
16 participants
n=17 Participants
Region of Enrollment
Switzerland
1 participants
n=17 Participants

PRIMARY outcome

Timeframe: every minute under apnea (from 0 up to 9 minutes and rest) depending on personal best with a mean of 5 measurements

Alteration of cardiac function in subjects undergoing maximum apnea.

Outcome measures

Outcome measures
Measure
Deliberate Apnea Group
n=17 Participants
Subjects undergo maximum apnea. magnetic resonance imaging (MRI)
Cardiac Function: Duration of Apnea
483 sec
Standard Deviation 582

PRIMARY outcome

Timeframe: Every minute under apnea (from 0 up to 9 minutes and rest) depending on personal best with a mean of 5 measurements

Blood flow pattern in subjects undergoing maximum apnea.

Outcome measures

Outcome measures
Measure
Deliberate Apnea Group
n=17 Participants
Subjects undergo maximum apnea. magnetic resonance imaging (MRI)
Mean Blood Flow Measurement Under Apnea Using MRI
82 ml/s
Standard Deviation 27

Adverse Events

Deliberate Apnea Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Jonas Doerner

University of Bonn

Phone: 017632817006

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place